Company profile
89bio
Developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases
- Industry
- Biotechnology Research
- Employees
- 119
- Headquarters
- San Francisco, CA
- Founded
- 2018
- LinkedIn followers
- 14,859
- Office locations
- 1
89bio company summary
89bio is a company in the Biotechnology Research industry, headquartered in San Francisco, CA, founded in 2018. On LinkedIn the company has around 119 employees and 14,859 followers. Its listed specialties include Biopharmaceutical.
What technology does 89bio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About 89bio
89bio was acquired by Roche in September 2025, making the company a member of the Roche Group. We look forward to advancing our innovative FGF21 analog, pegozafermin, as part of Roche’s Pharmaceuticals Division and continuing our mission to help patients with serious liver and cardiometabolic diseases. Pegozafermin is currently being evaluated in Phase 3 trials for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG).
Specialties
Where is 89bio located?
89bio lists 1 location.
Compare companies similar to 89bio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
89bio 89bio.com | Biotechnology Research | 119 | 2018 | San Francisco, CA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about 89bio
What does 89bio do?
89bio was acquired by Roche in September 2025, making the company a member of the Roche Group. We look forward to advancing our innovative FGF21 analog, pegozafermin, as part of Roche’s Pharmaceuticals Division and continuing our mission to help patients with serious liver and cardiometabolic diseases. Pegozafermin is currently being evaluated in Phase 3 trials for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG).
How many employees does 89bio have?
89bio has around 119 employees on LinkedIn.
Where is 89bio headquartered?
89bio is headquartered in San Francisco, CA.
When was 89bio founded?
89bio was founded in 2018.
Build a lead list from companies like 89bio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.